Interim positron emission tomography/computed tomography as a major prognostic factor of treatment outcome in newly diagnosed Hodgkin’s lymphoma and optimization of the therapeutic approach
Open Access
- 1 January 2023
- journal article
- research article
- Published by National Library of Serbia in Medicinski Pregled
- Vol. 76 (3-4) , 92-98
Abstract
Introduction. During the last decade, the interim positron emission tomography/computed tomography has emerged as the most important prognostic factor in patients with newly diagnosed Hodgkin’s lymphoma. The aim of this study was to analyze the treatment of patients at the Clinic of Hematology, University Clinical Center of Vojvodina, in order to evaluate the prognostic value of key risk factors, with a particular focus on the role of interim positron emission tomography/ computed tomography. Material and Methods. The study included 22 of 29 patients with a newly diagnosed classic Hodgkin’s lymphoma, i.e. all patients in whom the first therapy response assessment was based on positron emission tomography/computed tomography scan results. Relevant data were collected from medical records. Kaplan-Meier curves and log-rank tests were used for survival analysis. Univariate Cox regression was used to assess the predictive value of each variable for progression-free survival. Results. The study included 13 women (59.09%) and 9 men (40.91%), aged 18 to 73 years (median 39.5 years). Univariate analysis was used to analyze the statistical significance of three examined variables: gender, presence of B symptoms, and complete remission on interim positron emission tomography/computed tomography. Multivariate analysis was not performed due to the insufficient number of patients for adequate interpretation of results. Conclusion. Interim positron emission tomography/ computed tomography is the main prognostic factor in predicting treatment response and disease outcome in patients with newly diagnosed Hodgkin’s lymphoma.Keywords
This publication has 28 references indexed in Scilit:
- International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: Altered Utility in the Modern EraJournal of Clinical Oncology, 2012
- Molecular Pathogenesis of Hodgkin's Lymphoma: Increasing Evidence of the Importance of the MicroenvironmentJournal of Clinical Oncology, 2011
- Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography for Interim Response Assessment of Advanced-Stage Hodgkin's Lymphoma and Diffuse Large B-Cell Lymphoma: A Systematic ReviewJournal of Clinical Oncology, 2009
- Report on the First International Workshop on interim-PET scan in lymphomaLeukemia & Lymphoma, 2009
- Positron emission tomography in the staging of patients with Hodgkin’s lymphoma. A prospective multicentric study by the Intergruppo Italiano LinfomiAnnals of Hematology, 2007
- Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphomaAnnals of Oncology, 2005
- Contribution of PET imaging to the initial staging and prognosis of patients with Hodgkin's diseaseAnnals of Oncology, 2004
- Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin's diseaseAnnals of Hematology, 2001
- The World Health Organization Classification of Hematological Malignancies Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997Laboratory Investigation, 2000
- A Prognostic Score for Advanced Hodgkin's DiseaseNew England Journal of Medicine, 1998